表紙
市場調查報告書
商品編碼
1035946

類鴉片物質止痛藥的全球市場規模調查:各藥物類別,各適應症,各給藥途徑,各終端用戶,各地區預測(2021年∼2027年)

Global Opioid Analgesics Market Size study, by Drug Class, By Indication, By Route of Administration, By End User and Regional Forecasts 2021-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

癌症,整形外科疾病,神經性疼痛,老年人的慢性疼痛等的發生率上升,成為類鴉片物質止痛藥的全球市場的主要推動要素。

還有醫療費增加和可支配所得增加等,也促進該市場。

根據衛生署,一般認為在紐約州成人的約40%患慢性疾病病,州內的23%由於慢性疾病住院。可是,為了避開中毒和使用過量的可能性,類鴉片物質銷售實施嚴格法規,在2021年∼2027年的預測期間中有可能妨礙市場成長。還有個人化醫療的普及,有提高在預測期間內的市場成長的可能性。

本報告提供類鴉片物質止痛藥的全球市場調查,市場概要,以及各類藥物,各適應症,各給藥途徑,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 類鴉片物質止痛藥的全球市場定義和範圍

第3章 類鴉片物質止痛藥的全球市場動態

  • 類鴉片物質止痛藥市場影響分析(2019年∼2027年)

第4章 類鴉片物質止痛藥的全球市場產業分析

  • 波特的5力模式
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 類鴉片物質止痛藥的全球市場,各類藥物

  • 市場概述
  • 類鴉片物質止痛藥的全球市場,各類藥物:效能-潛在性分析
  • 類鴉片物質止痛藥的全球市場的預算與預測,各類藥物:2018年∼2027年(10億美元)
  • 類鴉片物質止痛藥市場,子區隔分析
    • 嗎啡
    • Codeine
    • Fentanyl
    • Meperidine
    • 美沙酮
    • Tramadol
    • Oxycodone
    • Dextromethorphan
    • Buprenornhine
    • 其他

第6章 類鴉片物質止痛藥的全球市場,各給藥途徑

  • 市場概述
  • 類鴉片物質止痛藥的全球市場,各給藥途徑:效能-潛在性分析
  • 類鴉片物質止痛藥的全球市場的預算與預測,各給藥途徑:2018年∼2027年(10億美元)
  • 類鴉片物質止痛藥市場,子區隔分析
    • 口服
    • 非口服
    • 經皮
    • 其他

第7章 類鴉片物質止痛藥的全球市場,各適應症

  • 市場概述
  • 類鴉片物質止痛藥的全球市場,各適應症:效能-潛在性分析
  • 類鴉片物質止痛藥的全球市場的預算與預測,各適應症:2018年∼2027年(10億美元)
  • 類鴉片物質止痛藥市場,子區隔分析
    • 外科性疼痛
    • 癌症性疼痛
    • 神經性疼痛
    • 其他

第8章 類鴉片物質止痛藥的全球市場,各終端用戶

  • 市場概述
  • 類鴉片物質止痛藥的全球市場,各終端用戶:效能-潛在性分析
  • 類鴉片物質止痛藥的全球市場的預算與預測,各終端用戶:2018年∼2027年(10億美元)
  • 類鴉片物質止痛藥市場,子區隔分析
    • 醫院
    • 零售藥局
    • 藥妝店
    • 線上藥局

第9章 類鴉片物質止痛藥的全球市場,地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭資訊

  • 最高市場策略
  • 企業簡介
    • Pfizer Inc.
    • Abbott Laboratories
    • Janssen Pharmaceuticals, Inc.
    • Novartis AG
    • Bayer AG
    • GlaxoSmithKline plc
    • F. Hoffmann-La Roche AG,
    • Boehringer Ingelheim International GmbH
    • Bausch Health Companies Inc.
    • Sanofi S.A.

第11章 調查流程

目錄

Global Opioid Analgesics Market is valued approximately xxx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xxx over the forecast period 2021-2027. Opioids are well known as the most effective drugs for pain management. Their implementation in chronic pain management is a standard procedure in several countries across the world. Growing incidence of cancer, orthopedic diseases, neuropathic pain and chronic pain among the geriatric population serves as key driver for the market. Increasing expenditure on healthcare and increasing disposable income are some other factors driving the Opioid Analgesics Market. Crocin, a medicine which is available in liquid as well as solid form is manufactured by leading analgesics GlaxoSmithKline Asia Private Limited (GSKAP). World Health Organization (WHO) recommends a three-level ladder approach to pain management, which includes the use of drugs with opioid contents. According to Department of Health, about 40% of adults in New York State suffer from a chronic disease and 23% of the state's hospitalization is due to chronic diseases. However, to avoid the chances of addiction and overuse, strict regulations are imposed on sales of opioids which may impede the growth of the market over the forecast period of 2021-2027. Also, the increase in popularity of personalized medicine is likely to increase the market growth during the forecast period.

The regional analysis of global Opioid Analgesics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing chronic illnesses and growing consumption of opioids as a pain medication are expected to continue boosting sales of opioid analgesics. Whereas, Asia-Pacific is also anticipated to exhibit highest CAGR over the forecast period 2021-2027. Factors such as increasing utilization of high amounts of opioids for pain management would create lucrative growth prospects for the Opioid Analgesics Market across Asia-Pacific region.

Major market player included in this report are:

Pfizer Inc.

Abbott Laboratories

Janssen Pharmaceuticals, Inc. [Johnson & Johnson]

Novartis AG

Bayer AG

GlaxoSmithKline plc

F. Hoffmann-La Roche AG,

Boehringer Ingelheim International GmbH

Bausch Health Companies Inc.

Sanofi S.A.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class

Morphine

Codeine

Fentanyl

Meperidine

Methadone

Tramadol

Oxycodone

Dextromethorphan

Buprenorphine

Others

By Ownership:

Surgical Pain

Cancer Pain

Neuropathic Pain

Other

By Route of Administration:

Oral

Parenteral

Transdermal

Other

By End User:

Hospitals

Retail Pharmacies

Drug Stores

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Opioid Analgesics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Opioid Analgesics Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Opioid Analgesics Market, by Drug Class, 2019-2027 (USD Billion)
    • 1.2.3. Opioid Analgesics Market, by Route of Administration, 2019-2027 (USD Billion)
    • 1.2.4. Opioid Analgesics Market, by Indication, 2019-2027 (USD Billion)
    • 1.2.5. Opioid Analgesics Market, by End-User, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Opioid Analgesics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Opioid Analgesics Market Dynamics

  • 3.1. Opioid Analgesics Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing chronic illnesses
      • 3.1.1.2. Increasing expenditure on healthcare
    • 3.1.2. Market Challenges
      • 3.1.2.1. Strict government policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in popularity of personalized medicine

Chapter 4. Global Opioid Analgesics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Opioid Analgesics Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Opioid Analgesics Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Opioid Analgesics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
  • 5.4. Opioid Analgesics Market, Sub Segment Analysis
    • 5.4.1. Morphine
    • 5.4.2. Codeine
    • 5.4.3. Fentanyl
    • 5.4.4. Meperidine
    • 5.4.5. Methadone
    • 5.4.6. Tramadol
    • 5.4.7. Oxycodone
    • 5.4.8. Dextromethorphan
    • 5.4.9. Buprenorphine
    • 5.4.10. Others

Chapter 6. Global Opioid Analgesics Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Opioid Analgesics Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Opioid Analgesics Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
  • 6.4. Opioid Analgesics Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Parenteral
    • 6.4.3. Transdermal
    • 6.4.4. Other

Chapter 7. Global Opioid Analgesics Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Opioid Analgesics Market by Indication, Performance - Potential Analysis
  • 7.3. Global Opioid Analgesics Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
  • 7.4. Opioid Analgesics Market, Sub Segment Analysis
    • 7.4.1. Surgical Pain
    • 7.4.2. Cancer Pain
    • 7.4.3. Neuropathic Pain
    • 7.4.4. Other

Chapter 8. Global Opioid Analgesics Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Global Opioid Analgesics Market by End-User, Performance - Potential Analysis
  • 8.3. Global Opioid Analgesics Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
  • 8.4. Opioid Analgesics Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Drug Stores
    • 8.4.4. Online Pharmacies

Chapter 9. Global Opioid Analgesics Market, Regional Analysis

  • 9.1. Opioid Analgesics Market, Regional Market Snapshot
  • 9.2. North America Opioid Analgesics Market
    • 9.2.1. U.S. Opioid Analgesics Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Indication breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. End-User breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Opioid Analgesics Market
  • 9.3. Europe Opioid Analgesics Market Snapshot
    • 9.3.1. U.K. Opioid Analgesics Market
    • 9.3.2. Germany Opioid Analgesics Market
    • 9.3.3. France Opioid Analgesics Market
    • 9.3.4. Spain Opioid Analgesics Market
    • 9.3.5. Italy Opioid Analgesics Market
    • 9.3.6. Rest of Europe Opioid Analgesics Market
  • 9.4. Asia-Pacific Opioid Analgesics Market Snapshot
    • 9.4.1. China Opioid Analgesics Market
    • 9.4.2. India Opioid Analgesics Market
    • 9.4.3. Japan Opioid Analgesics Market
    • 9.4.4. Australia Opioid Analgesics Market
    • 9.4.5. South Korea Opioid Analgesics Market
    • 9.4.6. Rest of Asia Pacific Opioid Analgesics Market
  • 9.5. Latin America Opioid Analgesics Market Snapshot
    • 9.5.1. Brazil Opioid Analgesics Market
    • 9.5.2. Mexico Opioid Analgesics Market
  • 9.6. Rest of The World Opioid Analgesics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Abbott Laboratories
    • 10.2.3. Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
    • 10.2.4. Novartis AG
    • 10.2.5. Bayer AG
    • 10.2.6. GlaxoSmithKline plc
    • 10.2.7. F. Hoffmann-La Roche AG,
    • 10.2.8. Boehringer Ingelheim International GmbH
    • 10.2.9. Bausch Health Companies Inc.
    • 10.2.10. Sanofi S.A.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Opioid Analgesics Market, report scope
  • TABLE 2. Global Opioid Analgesics Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Opioid Analgesics Market estimates & forecasts by Drug Class 2018-2027 (USD Billion)
  • TABLE 4. Global Opioid Analgesics Market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
  • TABLE 5. Global Opioid Analgesics Market estimates & forecasts by Indication 2018-2027 (USD Billion)
  • TABLE 6. Global Opioid Analgesics Market estimates & forecasts by End-User 2018-2027 (USD Billion)
  • TABLE 7. Global Opioid Analgesics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Opioid Analgesics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Opioid Analgesics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Opioid Analgesics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Opioid Analgesics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Opioid Analgesics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Opioid Analgesics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Opioid Analgesics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Opioid Analgesics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Opioid Analgesics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. U.S. Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. U.S. Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Canada Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. Canada Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. UK Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. UK Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Germany Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Germany Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. RoE Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. RoE Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. China Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. China Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. India Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. India Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Japan Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Japan Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. RoAPAC Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. Brazil Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Brazil Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. Mexico Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. Mexico Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. RoLA Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. RoLA Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row Opioid Analgesics Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Row Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Row Opioid Analgesics Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Opioid Analgesics Market
  • TABLE 57. List of primary sources, used in the study of global Opioid Analgesics Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Opioid Analgesics Market, research methodology
  • FIG 2. Global Opioid Analgesics Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Opioid Analgesics Market, key trends 2020
  • FIG 5. Global Opioid Analgesics Market, growth prospects 2021-2027
  • FIG 6. Global Opioid Analgesics Market, porters 5 force model
  • FIG 7. Global Opioid Analgesics Market, pest analysis
  • FIG 8. Global Opioid Analgesics Market, value chain analysis
  • FIG 9. Global Opioid Analgesics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Opioid Analgesics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Opioid Analgesics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Opioid Analgesics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Opioid Analgesics Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Opioid Analgesics Market, regional snapshot 2018 & 2027
  • FIG 15. North America Opioid Analgesics Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Opioid Analgesics Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Opioid Analgesics Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Opioid Analgesics Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Opioid Analgesics Market, company market share analysis (2020)